InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,751.07
(
0.90%
)
US TECH 100
19,476.00
(
1.10%
)
Dow Jones
42,352.75
(
0.81%
)
Brent Oil
77.97
(
0.00%
)
Bitcoin
62,297.25
(
0.36%
)

Replies to post #24952 on MannKind Corp. (MNKD)

Replies to #24952 on MannKind Corp. (MNKD)
icon url

$Pistol Pete$

08/17/17 10:29 PM

#24953 RE: TREND1 #24952

$MNKD Daily and Weekly Charts



icon url

$Pistol Pete$

08/17/17 10:30 PM

#24954 RE: TREND1 #24952

$MNKD https://www.smarteranalyst.com/2017/08/11/maxim-sees-200-upside-mannkind-corporation-mnkd/
Maxim Sees Over 200% Upside for MannKind Corporation (MNKD)
Smarter Analyst - Aug 11, 2017


“We model Afrezza in adult diabetes, followed by launch for pediatrics in 2021. Given the challenges associated with the Sanofi launch and the early stage of the MannKind relaunch, a risk cut of 30% is applied to the adult diabetes model. A risk cut of ...